Osteoporosis: taking a fresh look.
Risk factors are being refined; old ones are being dropped and new ones are being added. Early detection-before fracture occurs-with bone-density assessment represents another important advance. Several strategies are now available to inhibit bone loss, and means are in prospect to promote bone formation directly. Of these, alendronate and slow-release fluoride appear to have particular promise.
Barzel
U S
US
Albert Einstein College of Medicine, Bronx, New York, USA.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D001862:Bone Resorption; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors
D004164:Diphosphonates; D002116:Calcitonin